LCN2 and chronic kidney disease: Nevertheless, Hsu et al. (46) conducted a prospective cohort study and found that after adjusting for known CKD progression risk factors including eGFR and ACR, tubular injury biomarkers such as KIM-1, NGAL, and NAG did not improve prediction of CKD progression.